Does a 70-year-old male with normal hemoglobin (Hb) of 13.9, hematocrit (Hct) of 40, serum iron of 42, and ferritin of 232 require iron supplementation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

No Iron Supplementation Needed

This 70-year-old male does not require iron supplementation—his ferritin of 232 ng/mL indicates adequate iron stores, his hemoglobin of 13.9 g/dL is normal for his age, and iron supplementation in the presence of normal or elevated ferritin is not recommended and potentially harmful. 1

Iron Status Assessment

Your patient's laboratory values indicate:

  • Ferritin 232 ng/mL: Well above the threshold for iron deficiency. Iron deficiency is defined by ferritin <15 ng/mL in the general population 2, and even in chronic kidney disease patients requiring erythropoietin, the target is only ≥100 ng/mL 1. His level of 232 ng/mL represents adequate to replete iron stores 3.

  • Hemoglobin 13.9 g/dL: This is normal for a 70-year-old male. Population data shows that 70-year-old men have a median hemoglobin of 142 g/dL with a 5-95 percentile range of 124-158 g/dL 3. His value falls comfortably within the normal range for adult males (13.5-17.5 g/dL) 1.

  • Serum iron 42 µg/dL: While this appears low compared to the reference range of 50-175 µg/dL 1, serum iron is heavily influenced by inflammation and diurnal variation, making it less reliable as an isolated marker 1.

Why Iron Supplementation Would Be Inappropriate

Iron supplementation should only be given when there is documented iron deficiency with anemia and/or low ferritin levels 1. The ESPEN guidelines explicitly state that "iron supplementation in the presence of normal or even high ferritin values is not recommended and is potentially harmful" 1.

The hemochromatosis guidelines reinforce this principle, strongly recommending that "iron supplementation should be avoided" when stores are adequate 1. Even in patients with chronic kidney disease on erythropoietin therapy—who have much higher iron requirements—supplementation is only indicated when ferritin is <100 ng/mL 1.

Clinical Context for Elderly Males

In a population study of 70-year-old men, 94.1% had ferritin values >30 ng/mL (indicating replete stores), with 74.4% having values between 61-300 ng/mL 3. Your patient's ferritin of 232 ng/mL places him in the upper half of this normal distribution, confirming adequate iron stores for his age.

Only 0.39% of 70-year-old men in this population had true iron deficiency anemia (defined as ferritin <15 ng/mL AND hemoglobin <129 g/dL) 3. Your patient meets neither criterion.

Important Caveats

  • Ferritin is an acute phase reactant: If there is underlying inflammation, infection, or malignancy, ferritin can be falsely elevated 1, 4. However, with "all other labs normal" as stated, this is less likely.

  • Transferrin saturation would be helpful: If available, calculate transferrin saturation (serum iron/TIBC × 100). A value <20% might suggest functional iron deficiency even with adequate ferritin 1, though this is primarily relevant in patients on erythropoietin therapy.

  • Monitor for occult blood loss: In a 70-year-old male, if hemoglobin were to decline or if true iron deficiency developed later, evaluation for gastrointestinal bleeding would be essential, as 9% of elderly patients with iron deficiency anemia have gastrointestinal cancer 2.

The appropriate management is observation without iron supplementation, with periodic reassessment if clinical status changes 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Iron deficiency anemia.

American family physician, 2007

Research

Iron status as measured by serum ferritin: the marker and its limitations.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.